Advanced Search
ZHANG Dongjie, MENG Hua, XIE Yuntao. Advances of BRCA1/2 Large Rearrangement in Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2017, 44(9): 622-626. DOI: 10.3971/j.issn.1000-8578.2017.17.0251
Citation: ZHANG Dongjie, MENG Hua, XIE Yuntao. Advances of BRCA1/2 Large Rearrangement in Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2017, 44(9): 622-626. DOI: 10.3971/j.issn.1000-8578.2017.17.0251

Advances of BRCA1/2 Large Rearrangement in Breast Cancer

  • Breast cancer is the most frequent female malignant tumor. BRCA1 and BRCA2 genes are important susceptibility genes of breast cancer. Mutations in BRCA1/2 genes lead to an increased risk of breast cancer in life-span. The most common mutations in BRCA1/2 genes are frameshift and nonsense mutations involving in one or several bases by Sanger-sequencing. However, large rearrangements of BRCA1/2 genes are hardly detected by conventional Sanger-sequencing. With the progress of gene detection technology, multiple BRCA1/2 gene rearrangements have been found, we need to take the large rearrangement into consideration when no mutation is found in traditional BRCA1/2 gene sequencing on the family of hereditary breast cancer, in order to avoid missed diagnosis.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return